The authors respond to "The 2017 Canadian opioid guideline: already time for an overhaul"
- PMID: 29530874
- PMCID: PMC5849453
- DOI: 10.1503/cmaj.68675
The authors respond to "The 2017 Canadian opioid guideline: already time for an overhaul"
Conflict of interest statement
Competing interests: All authors are members of the Steering Committee for the Canadian Guideline for Opioid Therapy and Chronic Noncancer Pain. David Juurlink was a member of the Stakeholder Review Group for the US Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain. No other competing interests were declared.
Comment on
-
Guideline for opioid therapy and chronic noncancer pain.CMAJ. 2017 May 8;189(18):E659-E666. doi: 10.1503/cmaj.170363. CMAJ. 2017. PMID: 28483845 Free PMC article. No abstract available.
-
The 2017 Canadian opioid guideline: already time for an overhaul.CMAJ. 2018 Mar 12;190(10):E300. doi: 10.1503/cmaj.68662. CMAJ. 2018. PMID: 29530873 Free PMC article. No abstract available.
References
-
- 2017 Canadian Guideline for Opioids for Chronic Non-cancer Pain Values & Preferences statement. Hamilton (ON): McMaster University; 2017. Available: http://nationalpaincentre.mcmaster.ca/documents/ValuesandPreferencesStat... (accessed 2017 Dec 1).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical